Search research articles
Contact Us
Filters
Showing results (261-270 of 359) with videos related to
Page
of 36
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2019
Phase I Trial of Well-Differentiated Neuroendocrine Tumors (NETs) with Radiolabeled Somatostatin Antagonist <sup>177</sup>Lu-Satoreotide Tetraxetan
Diane Reidy-Lagunes, Neeta Pandit-Taskar, Joseph A O'Donoghue, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 26, 2014
A modular labeling strategy for in vivo PET and near-infrared fluorescence imaging of nanoparticle tumor targeting
Carlos Pérez-Medina, Dalya Abdel-Atti, Yachao Zhang, et al.
Journal of Labelled Compounds & Radiopharmaceuticals
|
January 26, 2016
Radiosynthesis of the iodine-124 labeled Hsp90 inhibitor PU-H71
Tony Taldone, Danuta Zatorska, Stefan O Ochiana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2019
Retooling a Blood-Based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer
Christian Lohrmann, Eileen M O'Reilly, Joseph A O'Donoghue, et al.
Cancer Discovery
|
May 12, 2012
Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen
David Ulmert, Michael J Evans, Jason P Holland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 19, 2020
Targeted Brain Tumor Radiotherapy Using an Auger Emitter
Giacomo Pirovano, Stephen A Jannetti, Lukas M Carter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 21, 2022
Molecular Imaging of Neuroendocrine Prostate Cancer by Targeting Delta-Like Ligand 3
Joshua A Korsen, Teja M Kalidindi, Samantha Khitrov, et al.
Radiology
|
June 10, 2020
Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted <sup>89</sup>Zr-Pertuzumab PET/CT
Gary A Ulaner, Jorge A Carrasquillo, Christopher C Riedl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 14, 2013
Applying PET to broaden the diagnostic utility of the clinically validated CA19.9 serum biomarker for oncology
Nerissa Therese Viola-Villegas, Samuel L Rice, Sean Carlin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 23, 2022
Noninvasive Assessment of Human Epidermal Growth Factor Receptor 2 (HER2) in Esophagogastric Cancer Using <sup>89</sup>Zr-Trastuzumab PET: A Pilot Study
Melissa A Lumish, Steven B Maron, Viktoriya Paroder, et al.
Page
of 36
Search research articles
Search
Showing results (261-270 of 359) with videos related to
Sort By:
Page
of 36
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2019
Phase I Trial of Well-Differentiated Neuroendocrine Tumors (NETs) with Radiolabeled Somatostatin Antagonist <sup>177</sup>Lu-Satoreotide Tetraxetan
Diane Reidy-Lagunes, Neeta Pandit-Taskar, Joseph A O'Donoghue, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 26, 2014
A modular labeling strategy for in vivo PET and near-infrared fluorescence imaging of nanoparticle tumor targeting
Carlos Pérez-Medina, Dalya Abdel-Atti, Yachao Zhang, et al.
Journal of Labelled Compounds & Radiopharmaceuticals
|
January 26, 2016
Radiosynthesis of the iodine-124 labeled Hsp90 inhibitor PU-H71
Tony Taldone, Danuta Zatorska, Stefan O Ochiana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2019
Retooling a Blood-Based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer
Christian Lohrmann, Eileen M O'Reilly, Joseph A O'Donoghue, et al.
Cancer Discovery
|
May 12, 2012
Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen
David Ulmert, Michael J Evans, Jason P Holland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 19, 2020
Targeted Brain Tumor Radiotherapy Using an Auger Emitter
Giacomo Pirovano, Stephen A Jannetti, Lukas M Carter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 21, 2022
Molecular Imaging of Neuroendocrine Prostate Cancer by Targeting Delta-Like Ligand 3
Joshua A Korsen, Teja M Kalidindi, Samantha Khitrov, et al.
Radiology
|
June 10, 2020
Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted <sup>89</sup>Zr-Pertuzumab PET/CT
Gary A Ulaner, Jorge A Carrasquillo, Christopher C Riedl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 14, 2013
Applying PET to broaden the diagnostic utility of the clinically validated CA19.9 serum biomarker for oncology
Nerissa Therese Viola-Villegas, Samuel L Rice, Sean Carlin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 23, 2022
Noninvasive Assessment of Human Epidermal Growth Factor Receptor 2 (HER2) in Esophagogastric Cancer Using <sup>89</sup>Zr-Trastuzumab PET: A Pilot Study
Melissa A Lumish, Steven B Maron, Viktoriya Paroder, et al.
Page
of 36